Paragon 28 Inc. | Small-cap | Healthcare
$13.09
0.00%
| Paragon Stock Comparison:
Paragon vs Abbott LaboratoriesParagon vs Boston ScientificParagon vs NovocureParagon vs UFP TechnologiesParagon vs Alphatec HoldingsParagon vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 256.2M
Gross Profit 191.5M 74.75%
Operating Income -40.8M -15.92%
Net Income -54.6M -21.33%

Balance Sheet Metrics

Total Assets 290.7M
Total Liabilities 160.1M
Shareholders Equity 130.6M
Debt to Equity 1.23

Cash Flow Metrics

Operating Cash Flow -41.6M
Free Cash Flow -44.1M

Revenue & Profitability Trend

Paragon Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue256.2M216.4M181.4M147.5M111.0M
Cost of Goods Sold64.7M52.0M32.1M28.0M25.1M
Gross Profit191.5M164.4M149.3M119.4M85.9M
Operating Expenses232.3M210.1M184.0M130.2M83.8M
Operating Income-40.8M-45.7M-34.7M-10.8M2.1M
Pre-tax Income-53.5M-57.3M-65.7M-13.0M5.0M
Income Tax1.2M213.0K-64.0K713.0K1.5M
Net Income-54.6M-57.5M-65.6M-13.7M3.5M
EPS (Diluted)--$0.70-$0.87-$0.18$0.04

Income Statement Trend

Paragon Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets168.8M207.8M142.7M179.5M71.8M
Non-Current Assets121.9M124.9M113.1M55.0M25.8M
Total Assets290.7M332.7M255.8M234.5M97.6M
Liabilities
Current Liabilities48.1M51.2M68.5M34.0M22.1M
Non-Current Liabilities112.0M111.7M44.7M8.4M4.0M
Total Liabilities160.1M163.0M113.2M42.4M26.1M
Equity
Total Shareholders Equity130.6M169.7M142.6M192.2M71.5M

Balance Sheet Composition

Paragon Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-54.6M-57.5M-65.6M-13.7M3.5M
Operating Cash Flow-41.6M-55.4M-76.2M-17.0M-6.7M
Investing Activities
Capital Expenditures-14.5M-25.7M-40.2M-17.5M-9.1M
Investing Cash Flow-14.5M-25.7M-58.7M-32.5M-9.1M
Financing Activities
Dividends Paid-----
Financing Cash Flow-3.5M125.3M33.7M130.7M12.4M
Free Cash Flow-44.1M-91.9M-92.3M-24.6M-9.7M

Cash Flow Trend

Paragon Key Financial Ratios

Valuation Ratios

Forward P/E -27.85
Price to Book 8.41
Price to Sales 4.29
PEG Ratio -27.85

Profitability Ratios

Profit Margin -21.33%
Operating Margin -8.97%
Return on Equity -36.39%
Return on Assets -8.18%

Financial Health

Current Ratio 3.51
Debt to Equity 86.22
Beta 1.47

Per Share Data

EPS (TTM) -$0.66
Book Value per Share $1.56
Revenue per Share $3.08

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
fna1.1B-8.41-36.39%-21.33%86.22
Abbott Laboratories 231.9B17.314.7530.65%31.89%27.09
Boston Scientific 149.9B73.946.759.50%11.58%52.16
Novocure 1.9B-10.905.12-45.52%-26.41%192.49
UFP Technologies 1.9B29.895.2019.36%11.59%55.05
Alphatec Holdings 1.6B-9.63-18.581,144.21%-25.77%-6.76

Financial data is updated regularly. All figures are in the company's reporting currency.